Tuesday, March 02, 2021 3:28:58 PM
https://www.sec.gov/Archives/edgar/data/1074828/000116169721000135/form_8-k.htm
Item 8.01 Other Events.
In September 2020, Know Labs, Inc. (the “Company”) engaged Texas Biomedical Research Institute (“Texas Biomed”) to test its Particle™ bulb’s ability to inactivate the SARS-CoV-2 virus, the virus that causes COVID-19. On February 24, 2021, preliminary results were issued and confirmed by Texas Biomed that the Particle bulb can successfully inactivate the SARS-CoV-2 virus. The test results demonstrated a 95% reduction in the SARS-CoV-2 virus solution after 5 hours of exposure to the Particle bulb; a 99% reduction in 6 hours; and a 99.9% reduction in 8 hours. This data is still undergoing quality control verification and is not final. Nevertheless, it represents a material achievement for the Company and its subsidiary Particle, Inc., and potentially delivers a new resource for the control of the COVID-19 spread. A final report with official results will be published by Texas Biomed. A further announcement will be issued upon receipt and review of the final report.
Texas Biomed https://www.txbiomed.org/ is an independent, non-profit biomedical research institute specializing in infectious diseases. Home to a CDC-regulated biosafety level-4 laboratory, Texas Biomed develops vaccines and therapies to successfully treat some of the world’s deadliest diseases, including COVID-19. Texas Biomed performs both independent, grant-funded research and contract research for several national agencies and is supported by philanthropic organizations.
Particle is an everyday light bulb that both illuminates and safely disinfects surfaces at your home, office, or business. It works like a normal light bulb and fits standard light fixtures. It is available for pre-orders at its website, www.particlebulb.com.
Recent KNW News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/11/2024 09:23:58 PM
- Know Labs Study Published in IEEE Sensors Journal • Business Wire • 09/10/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2024 01:25:14 PM
- Know Labs, Inc. Announces $1.655 Million Public Offering • Business Wire • 08/16/2024 01:16:00 PM
- Know Labs, Inc. Reports Third Quarter FY 2024 Results • Business Wire • 08/14/2024 08:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 10:01:40 AM
- Know Labs, Inc. Announces Closing of $3.445 Million Public Offering • Business Wire • 08/12/2024 10:38:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/12/2024 09:00:15 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/08/2024 04:15:14 AM
- Know Labs, Inc. Announces Pricing of $3.445 Million Public Offering • Business Wire • 08/08/2024 12:50:00 AM
- Know Labs, Inc. to Host Review of Third Quarter Fiscal Year 2024 Results on August 14, 2024 • Business Wire • 08/06/2024 01:00:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 08/02/2024 08:15:55 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 07/25/2024 01:49:42 AM
- Know Labs Publishes Clinical Results in Leading Diabetes Journal • Business Wire • 07/11/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/11/2024 10:05:56 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 07/09/2024 08:38:26 PM
- Know Labs to Present at the American Diabetes Association’s Scientific Sessions • Business Wire • 06/21/2024 10:30:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 06/17/2024 08:52:17 PM
- Know Labs Joins the Industrial Participant Program of the Wyss Institute for Biologically Inspired Engineering at Harvard University • Business Wire • 06/05/2024 01:00:00 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 06/03/2024 06:11:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/29/2024 08:15:29 PM
- Know Labs Appoints Chris Somogyi as President, International • Business Wire • 05/16/2024 01:00:00 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM